Options Trading News

December 12, 2012  Wed 7:31 AM CT


Glaucoma Drug Going to Market

Sucampo Pharmaceuticals said that the Food and Drug Administration approved its Rescula drug for patients suffering open-angle glaucoma. The product will be marketed in the first quarter of next year. SCMP is up 14 percent before the bell on my tradeMONSTER platform.

Costco Earnings, Revenue Beat

Costco reported first-quarter earnings of $0.95 a share, beating the $0.93 consensus estimate. Revenue of $23.72 billion also beat the $23.67 billion expected by analysts. COST is up 1 percent in early trading.

Clearwire Up on Buyout Chatter

Clearwire popped yesterday on reports that Sprint Nextel would buy out minority investors Intel and Comcast. CLWR, which offers wireless broadband services, is active again this morning and is up another 3 percent in the premarket.

Share this article with your friends



The fastest money in the market
View full report »

Premium Services

Archived Webinar

Education & Strategy

The covered call and unhedged risk

I have written a few things on the Covered Call Strategy over the last two weeks. Please understand that those two previous articles plus this one do not constitute a proper, fully in-depth lesson on the Covered Call Strategy like we have in our classes at Option Monster Education. I have picked out a few topics that I believe were worth noting and today I am going to add the final one.

View more education articles »